Has Kais Alsharif, MD received payments from drug or device companies?

Yes. Drug and device makers reported $744 in general payments to Kais Alsharif, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kais Alsharif, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kais Alsharif, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kais Alsharif, MD

Interventional Pain Medicine · Long Beach, CANPI 1730380007

Payments from drug & device makers

$744in general payments, 2019–2025

Across 27 payments — averaging $27.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$358
Nevro Corp.$127
Pfizer$119
Vertex$46
Boston Scientific$40
Nalu Medical, Inc.$39
plus $14 from 1 others

What the payments were for

Food & beverage$744100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	10	$358
Nevro Corp.	5	$127
Pfizer	6	$119
Vertex	1	$46
Boston Scientific	2	$40
Nalu Medical, Inc.	2	$39
IBSA Pharma Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Proclaim Family of SCS IPGs$116

How this compares

$744 in reported general payments places this provider in the 25th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California →

Medicare billing

Part B allowed, 2024

$311,516

Medicare patients

327

Services billed

3,481

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	171	$2,715
Gabapentin	120	$1,331
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	39	$697
Acetaminophen-CodeineAcetaminophen With Codeine	62	$617
Pregabalin	24	$396
Tramadol Hcl	96	$391
Diclofenac Sodium	13	$299
Methocarbamol	23	$218
Oxycodone Hcl	11	$140
Meloxicam	33	$77
Baclofen	11	$49

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Long Beach

Sheldon JordanSanta Monica$3.1M
Ezekiel FinkBeverly Hills$2.3M
Matthew DotyOroville$1.3M
Tim LeierRancho Mirage$749K
Pragya GuptaEscondido$647K
Michael Verdolinla Mesa$563K
Standiford HelmOrange$476K
Patrick BuchananCamarillo$453K
Roy BrownlowSan Diego$452K
Andrew GermanovichRancho Mirage$408K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →